CPT-K5 (Q54814409)

From Wikidata

Jump to navigation Jump to search

cell line

CPT-K-5
CPTK5
RPMI 8402/CPTK5

Language	Label	Description	Also known as
English	CPT-K5	cell line	CPT-K-5 CPTK5 RPMI 8402/CPTK5

Statements

1 reference

Cellosaurus release 44

7 January 2023

cancer cell line

1 reference

Cellosaurus release 44

7 January 2023

parent cell line

1 reference

Cellosaurus release 44

7 January 2023

described by source

Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.

1 reference

Cellosaurus release 44

7 January 2023

Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug.

1 reference

Cellosaurus release 44

7 January 2023

Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites

1 reference

Cellosaurus release 44

7 January 2023

Characterization of Camptothecin-induced Genomic Changes in the Camptothecin-resistant T-ALL-derived Cell Line CPT-K5.

1 reference

Cellosaurus release 44

7 January 2023

established from medical condition

T-cell childhood acute lymphocytic leukemia

1 reference

Cellosaurus release 44

7 January 2023

derived from organism type

1 reference

Cellosaurus release 44

7 January 2023

Identifiers

1 reference

Cellosaurus release 44

7 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54814409&oldid=1861214688"